Bilgilendirme: Kurulum ve veri kapsamındaki çalışmalar devam etmektedir. Göstereceğiniz anlayış için teşekkür ederiz.

Publication:
Lenalidomide Provide Better Progression Free Survival Than Thalidomide and Bortezomib in the First Relapse of Multiple Myeloma Patients After Autologous Transplantation

dc.contributor.authorMalkan, U.
dc.contributor.authorBuyukasik, Y.
dc.contributor.authorDemiroglu, H.
dc.contributor.authorCiftciler, R.
dc.contributor.authorGunes, G.
dc.contributor.authorOkay, M.
dc.contributor.authorGoker, H.
dc.contributor.authorIDCiftciler, Rafiye/0000-0001-5687-8531
dc.contributor.authorIDMalkan, Umit Yavuz/0000-0001-5444-4895
dc.contributor.authorIDHaznedaroglu, Ibrahim C./0000-0001-8028-9462
dc.date.accessioned2020-06-21T13:06:49Z
dc.date.available2020-06-21T13:06:49Z
dc.date.issued2018
dc.departmentOMÜen_US
dc.department-temp[Malkan, U. -- Gunes, G.] Univ Hlth Sci, Diskapi Yildirim Beyazit Training & Res Hosp, Dept Hematol, Ankara, Turkey -- [Buyukasik, Y. -- Demiroglu, H. -- Ciftciler, R.] Hacettepe Univ, Sch Med, Dept Hematol, Ankara, Turkey -- [Okay, M. -- Aladag, E.en_US
dc.description9th International Eurasian Hematology Oncology Congress (EHOC) -- OCT 17-20, 2018 -- Istanbul, TURKEYen_US
dc.description.abstracten_US
dc.identifier.endpageS56en_US
dc.identifier.issn0145-2126
dc.identifier.issn1873-5835
dc.identifier.startpageS55en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/11416
dc.identifier.volume73en_US
dc.identifier.wosWOS:000447176600134
dc.language.isoenen_US
dc.publisherPergamon-Elsevier Science Ltden_US
dc.relation.journalLeukemia Researchen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleLenalidomide Provide Better Progression Free Survival Than Thalidomide and Bortezomib in the First Relapse of Multiple Myeloma Patients After Autologous Transplantationen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files